Top compounds associated with response to TUFM


Feature Type Standardized
Nominal ANOVA
mRNA MS-275 gCSI pan-cancer AAC -0.15 0.004
mRNA nelarabine CTRPv2 pan-cancer AAC -0.11 0.004
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.004
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.005
mRNA gossypol CTRPv2 pan-cancer AAC 0.11 0.005
mRNA AZD-2281 CTRPv2 pan-cancer AAC -0.099 0.005
mRNA elocalcitol CTRPv2 pan-cancer AAC 0.096 0.006
mRNA marinopyrrole A CTRPv2 pan-cancer AAC 0.12 0.007
mRNA Gemcitabine GDSC1000 pan-cancer AAC 0.097 0.007
mRNA semagacestat CTRPv2 pan-cancer AAC -0.1 0.007
Download CSV